Old Web
English
Sign In
Acemap
>
authorDetail
>
Hidetaka Hiramatsu
Hidetaka Hiramatsu
Eisai
Medicine
Perampanel
Epilepsy
Adverse effect
Internal medicine
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM).
2021
Ryan Edbert Husni
Leock Y. Ngo
Hirofumi Senokuchi
Anna Patten
Hidetaka Hiramatsu
Kazuaki Watanabe
Takamichi Yamamoto
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: the open‐label Study 342 (FREEDOM study)
2020
Takamichi Yamamoto
Sung Chul Lim
Hirotomo Ninomiya
Yuichi Kubota
Won Chul Shin
Dong Wook Kim
Dong-Jin Shin
Tohru Hoshida
Koji Iida
Taku Ochiai
Risa Matsunaga
Hiroyuki Higashiyama
Hidetaka Hiramatsu
Ji Hyun Kim
Show All
Source
Cite
Save
Citations (5)
Efficacy and Safety of Perampanel Monotherapy in Patients with Newly Diagnosed or Currently Untreated Recurrent Partial-Onset Seizures (POS): Final Analysis of Study 342 (FREEDOM) 4 and 8 mg/day Core Data (833)
2020
Neurology
Takamichi Yamamoto
Ji Hyun Kim
Sung Chul Lim
Hirotomo Ninomiya
Yuichi Kubota
Risa Matsunaga
Hidetaka Hiramatsu
Show All
Source
Cite
Save
Citations (0)
Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy.
2018
Seizure-european Journal of Epilepsy
Naotaka Usui
Naoki Akamatsu
Nobukazu Nakasato
Akihiro Ohnishi
Sunao Kaneko
Hidetaka Hiramatsu
Kazunori Saeki
Hideaki Miyagishi
Yushi Inoue
Show All
Source
Cite
Save
Citations (8)
1